Invention Grant
- Patent Title: Crystalline salts of a plasma kallikrein inhibitor
-
Application No.: US16671649Application Date: 2019-11-01
-
Publication No.: US10662160B1Publication Date: 2020-05-26
- Inventor: Yahya El-Kattan , Yarlagadda S. Babu
- Applicant: BioCryst Pharmaceuticals, Inc.
- Applicant Address: US NC Durham
- Assignee: BioCryst Pharmaceuticals, Inc.
- Current Assignee: BioCryst Pharmaceuticals, Inc.
- Current Assignee Address: US NC Durham
- Agency: Foley Hoag LLP
- Agent Dana M. Gordon
- Main IPC: C07D231/14
- IPC: C07D231/14 ; A61K9/00 ; A23L33/10
Abstract:
Disclosed are crystalline salts of Compound I, methods of preparing them, and related pharmaceutical preparations thereof. Also disclosed are methods of treatment using the crystalline salts of the invention.
Public/Granted literature
- US20200140389A1 CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR Public/Granted day:2020-05-07
Information query
